Filing Details

Accession Number:
0001487371-17-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-20 18:49:14
Reporting Period:
2017-01-19
Filing Date:
2017-01-20
Accepted Time:
2017-01-20 18:49:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1487371 Genmark Diagnostics Inc. GNMK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1366268 Faiz Jon Kayyem 5964 La Place Court
Carlsbad CA 92008
Svp, Research & Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-19 2,096 $0.00 153,643 No 4 M Direct
Common Stock Acquisiton 2017-01-19 11,535 $0.00 165,178 No 4 M Direct
Common Stock Disposition 2017-01-19 5,718 $12.47 159,460 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Market Stock Units Disposition 2017-01-19 2,096 $0.00 2,096 $0.00
Common Stock Market Stock Units Disposition 2017-01-19 5,927 $0.00 5,927 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,295 No 4 M Direct
11,853 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 61,651 Indirect HI Charitable Remainder Uni Trust
Common Stock 569,308 Indirect IFIN LP
Common Stock 82,934 Indirect The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000
Footnotes
  1. Based on actual achievement for the one-year performance period, the recipient was issued 194.6% of the market stock units ("MSUs") which vested as of December 31, 2016.
  2. The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted MSUs.
  3. Dr. Kayyem is the trustee of the HI Charitable Remainder Uni Trust, trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000 and the President of In-Motion LLC, the general partner of IFIN LP. Dr. Kayyem disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
  4. Each MSU represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index.
  5. The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.
  6. The MSUs vest in three equal installments, on each of December 31, 2016, December 31, 2017, and December 31, 2018; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.